πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 185 of 200 Β· A–Z by INN

  1. tocofersolan

    VEDROP

    EMA: approved

    A11HA08
  2. tofacitinib

    XELJANZ Pfizer Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L04AF01
  3. tofacitinib citrate

    XELJANZ INITIAL APPROVAL

    ORAL FDA: approved Β· PMDA: approved

  4. tofersen

    QALSODY

    INTRATHECAL FDA: approved Β· EMA: approved Β· PMDA: approved

    N07XX22
  5. tolazamide

    TOLAZAMIDE

    ORAL FDA: approved

  6. tolazoline hydrochloride

    PRISCOLINE

    INJECTION FDA: approved

  7. tolbutamide

    TOLBUTAMIDE

    ORAL FDA: approved

  8. tolbutamide sodium

    ORINASE DIAGNOSTIC

    INJECTION FDA: approved

  9. tolcapone

    TASMAR

    ORAL FDA: approved Β· EMA: approved

    N04BX01
  10. tolebrutinib

    CENRIFKI

    EMA: unknown

  11. tolmetin sodium

    TOLECTIN DS

    ORAL FDA: approved

  12. tolnaftate

    TINADERM Bayer Australia Ltd

    TGA: approved

  13. tolterodine

    NMPA: clinical trials

  14. tolterodine tartrate

    TOLTERODINE TARTRATE Teva Pharma GmbH

    ORAL FDA: approved

  15. tolvaptan

    JINARC Otsuka Beijing Research Institute

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    C03XA01
  16. tolvaptan sodium phosphate

    SAMTASU

    PMDA: approved

  17. tongzhi

    NMPA: clinical trials

  18. topiramate

    APO-TOPIRAMATE Alphapharm Pty Ltd

    ORAL FDA: approved Β· TGA: approved Β· PMDA: approved

  19. topiroxostat

    TOPILORIC/URIADEC

    PMDA: approved

  20. topotecan

    HYCAMTIN Accord Healthcare Pty.

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01CE01
  21. topotecan hydrochloride

    TOPOTECAN HYDROCHLORIDE

    ORAL FDA: approved

  22. toremifene

    FARESTON Orion Laboratories Pty.

    EMA: approved Β· TGA: approved

    L02BA02
  23. toremifene citrate

    TOREMIFENE CITRATE

    ORAL FDA: approved

  24. toripalimab

    ZYTORVI Dr Reddy''s Laboratories (Australia) Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FF13

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources